KBLB OTC
Kraig Biocraft Laboratories, Inc.
1W: +38.9%
1M: +18.3%
3M: -10.2%
YTD: +13.8%
1Y: +8.0%
3Y: +223.3%
5Y: +21.2%
$0.10
-0.01 (-10.19%)
Weekly Expected Move ±22.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$3.37T
-109749265.9% ▼
Net Income
-$3.62T
-106600459.0% ▼
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$3.37T
-118697856.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $3.7B | $28K | $28K | $26K | $0 |
| Gross Profit | -$3.7B | -$28K | -$28K | -$26K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $198K | $176K | $238K | $164.4B | $165.8B |
| SG&A Expenses | $3M | $2M | $2M | $2.04T | $2.34T |
| Operating Expenses | $3M | $2M | $3M | $3M | $3.37T |
| Operating Income | -$3M | -$2M | -$3M | -$3M | -$3.37T |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $660K | $609K | $485K | -$529.6B | -$570.7B |
| Income Before Tax | -$8M | -$4M | -$3M | -$3M | -$3.62T |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8M | -$4M | -$3M | -$3M | -$3.62T |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.00 | $-0.00 | $0.00 |
| EBITDA | -$3M | -$2M | -$3M | -$3M | -$3.37T |
| Shares Outstanding | 878M | 974M | 1.03B | 1.04B | 1.06B |